PDC and acute myeloid leukemia: Given that IOX5 inhibits PHD-mediated HIF-α degradation, we compared the dysregulated pathways in AML cells treated with IOX5 to those lacking HIF-α, that is Hif1/2aDKO AML cells exposed to hypoxia6.